VIMTA LABS Financial Statement Analysis
|
||
|
The Revenues of VIMTA LABS have increased by 32.09% YoY .
The Earnings Per Share (EPS) of VIMTA LABS has increased by 16.48 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
VIMTA LABS Last 5 Annual Financial Results
[BOM: 524394|NSE : VIMTALABS]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|
| Revenues | ₹278 Cr | ₹211 Cr | ₹181 Cr | ₹181 Cr |
| Expenses | ₹198 Cr | ₹158 Cr | ₹151 Cr | ₹151 Cr |
| Operating Profit (Excl OI) | ₹80 Cr | ₹53 Cr | ₹30 Cr | ₹30 Cr |
| Other Income | ₹1.45 Cr | ₹0.83 Cr | ₹3.02 Cr | ₹3.02 Cr |
| Interest | ₹1.50 Cr | ₹2.17 Cr | ₹3.77 Cr | ₹3.77 Cr |
| Depreciation | ₹23 Cr | ₹23 Cr | ₹21 Cr | ₹21 Cr |
| Profit Before Tax | ₹56 Cr | ₹29 Cr | ₹8.27 Cr | ₹8.27 Cr |
| Profit After Tax | ₹41 Cr | ₹21 Cr | ₹6.85 Cr | ₹6.85 Cr |
| Consolidated Net Profit | ₹41 Cr | ₹21 Cr | ₹6.85 Cr | ₹6.85 Cr |
| Earnings Per Share (Rs) | ₹21.77 | ₹18.69 | ₹9.68 | ₹3.10 |
| PAT Margin (%) | 15.14 | 14.85 | 10.16 | 3.79 |
| ROE(%) | 19.02 | 19.43 | 11.66 | 3.96 |
| ROCE(%) | 24.59 | 23.92 | 14.25 | 5.84 |
| Total Debt/Equity(x) | 0.05 | 0.08 | 0.16 | 0.19 |
Key Financials |
||
| Market Cap | : | ₹ 1,062.9 Cr |
| Revenue (TTM) | : | ₹ 320.4 Cr |
| Net Profit(TTM) | : | ₹ 41.3 Cr |
| EPS (TTM) | : | ₹ 18.6 |
| P/E (TTM) | : | 25.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VIMTA LABS | -2.5% | -9.8% | 42% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
VIMTA LABS Revenues
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 32.09 % |
| 5 Yr CAGR | 15.48 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹278 Cr | 32.09 | |
| Mar2022 | ₹211 Cr | 16.58 | |
| Mar2021 | ₹181 Cr | 0.00 | |
| Mar2020 | ₹181 Cr | - | |
VIMTA LABS Operating Profit
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 51.61 % |
| 5 Yr CAGR | 38.92 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹80 Cr | 51.61 | |
| Mar2022 | ₹53 Cr | 76.82 | |
| Mar2021 | ₹30 Cr | 0.00 | |
| Mar2020 | ₹30 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 14.76 % |
| 5 Yr CAGR | 20.30 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 28.85% | 14.76 | |
| Mar2022 | 25.14% | 51.72 | |
| Mar2021 | 16.57% | 0.00 | |
| Mar2020 | 16.57% | - | |
VIMTA LABS Profit After Tax
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 93.09 % |
| 5 Yr CAGR | 82.09 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹41 Cr | 93.09 | |
| Mar2022 | ₹21 Cr | 212.71 | |
| Mar2021 | ₹6.85 Cr | 0.00 | |
| Mar2020 | ₹6.85 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 1.95 % |
| 5 Yr CAGR | 58.67 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 15.14 % | 1.95 | |
| Mar2022 | 14.85 % | 46.16 | |
| Mar2021 | 10.16 % | 168.07 | |
| Mar2020 | 3.79 % | - | |
VIMTA LABS Earnings Per Share (EPS)
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 16.48 % |
| 5 Yr CAGR | 91.50 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹22 | 16.48 | |
| Mar2022 | ₹19 | 93.08 | |
| Mar2021 | ₹9.68 | 212.26 | |
| Mar2020 | ₹3.10 | - | |
VIMTA LABS Return on Capital Employed (ROCE)
[BOM: 524394|NSE : VIMTALABS]
| Y-o-Y | 2.80 % |
| 5 Yr CAGR | 61.48 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 24.59% | 2.80 | |
| Mar2022 | 23.92% | 67.86 | |
| Mar2021 | 14.25% | 144.01 | |
| Mar2020 | 5.84% | - | |
VIMTA LABS Share Price vs Sensex
| Current Share Price | : | ₹478.8 |
| Current MarketCap | : | ₹ 1,062.9 Cr |
| Updated EOD on | : | Apr 23,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -2.5% |
-9.8% |
42% |
| SENSEX | 0.5% |
1.4% |
23.5% |
VIMTA LABS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 2.9% | 10.7% | 64.6% |
| S&P BSE MIDSMALLCAP | 1.9% | 8.5% | 63.5% |
| S&P BSE ALLCAP | 1% | 4.4% | 39.7% |
| S&P BSE HEALTHCARE | -0.9% | 1.1% | 50.9% |
No NSE index found
You may also like the below Video Courses
FAQ about VIMTA LABS Financials
How the annual revenues of VIMTA LABS have changed ?
The Revenues of VIMTA LABS have increased by 32.09% YoY .
How the Earnings per Share (EPS) of VIMTA LABS have changed?
The Earnings Per Share (EPS) of VIMTA LABS has increased by 16.48 % YoY .
Check out Intrinsic Value of Peers of VIMTA LABS
Compare Stock Analytics of Peers of VIMTA LABS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
